Stay updated on Nivolumab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no substantive changes to study details, eligibility criteria, or page navigation were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T18:24:52.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page no longer displays the government funding lapse notice and NIH Clinical Center operating status guidance. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:59:59.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The core study details and eligibility criteria appear unchanged between the two screenshots; only minor UI formatting differences are visible.
    Difference
    0.3%
    Check dated 2025-11-03T12:36:49.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-05T17:23:46.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Update the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.
    Difference
    0.1%
    Check dated 2025-09-28T10:11:06.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' control was removed.
    Difference
    0.2%
    Check dated 2025-09-14T00:21:53.000Z thumbnail image

Stay in the know with updates to Nivolumab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Hodgkin Lymphoma Clinical Trial page.